Bill

Bill > H2101


MA H2101

Patient pioid notification act


summary

Introduced
03/29/2021
In Committee
03/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

Relative to the issuing of the initial prescription of Schedule II controlled dangerous substances or other opioid pain relievers. Mental Health, Substance Use and Recovery.

AI Summary

This bill amends the existing law to require practitioners to discuss the risks associated with prescribing Schedule II controlled substances or other opioid pain relievers with patients, or their parents/guardians if the patient is under 18 and not an emancipated minor, before issuing the initial prescription and again before the third prescription in a course of treatment. The discussion must cover the risks of addiction and overdose, the reason for the prescription, alternative treatments, and the risks of dependence and using the medication improperly or with other central nervous system depressants. Practitioners must make a note in the patient's medical record that this discussion has occurred. The bill provides exceptions for patients in active cancer treatment, hospice/palliative care, long-term care facilities, or receiving treatment for substance abuse or opioid dependence.

Committee Categories

Health and Social Services

Sponsors (7)

Last Action

Accompanied a study order, see H5225 (on 09/22/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...